About Zambon Pharma
Zambon Pharma is a Healthcare company based in Bresso (Italy) founded in 1906. APIs and finished drugs are developed and manufactured in pharmaceuticals. Zambon Pharma has completed 1 acquisition, including Breath Therapeutics. Its chief executive, as recorded, is Roberto Tascione. Its website zambon.com draws about 35 thousand monthly visits. Its Indian entity Zambon India Private Limited reported revenue of ₹41.8 Lakh. Zambon Pharma offers products and services including Zambon Pharma, Zach System, and Zcube. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Formulation.
Company details
Zambon Pharma was founded in 1906 in Bresso, Italy, within the pharmaceutical sector. Active pharmaceutical ingredients and finished drugs are developed and manufactured, alongside research and development focused on patient health improvements. A subsidiary handles digital health technologies to support traditional treatments. A scientific campus is maintained for partnerships in health, science, and innovation. Operations cover the full value chain from research through production and distribution.
- Headquarters Bresso, Italy
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website zambon.com/en
- Social LinkedIn X Instagram YouTube
- Legal Name Zambon India Private Limited
- Date of Incorporation 19 Jun, 2002
- Jurisdiction New Delhi, Delhi, India
- Indian entity revenue₹41.8 Lakh
FY 2023 · -2% YoY
- Indian entity net loss-₹51.5 Lakh
FY 2023 · -123% margin
- Indian entity EBITDA-₹51.5 Lakh
FY 2023 · -123% margin
- Investors
- Investments & Acquisitions
Associated legal entities of Zambon Pharma
Zambon Pharma operates through Zambon India Private Limited (strike off). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Zambon India Private Limited CIN U51397DL2002PTC115876 | Strike Off | 19 Jun 2002 | New Delhi, Delhi | ₹0.4 Cr | 2 | View details |
Products & Services of Zambon Pharma
Zambon Pharma offers a comprehensive portfolio of products and services, including Zambon Pharma, Zach System, and Zcube.
Develops drugs and therapies to enhance patient health
Manufactures active ingredients for pharmaceutical use
Creates digital health innovations for patient support
Apps and channels of Zambon Pharma
its YouTube channel Zambon has 70 subscribers and 30 videos.
Videos from Zambon Pharma
The most watched videos on Zambon Pharma's YouTube channel, Zambon (70 subscribers). Click a video to play it here.
More on Zambon.
Funding Insights of Zambon Pharma
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Zambon Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2012 | Debt – Conventional | – | – |
1 investors in total: 1 institutional.
Investors in Zambon Pharma
Zambon Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include European Investment Bank.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Finance and advisory services for infrastructure projects are provided. | 1958 | eib.org | Luxembourg, Luxembourg |
Investor details for Zambon Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Zambon India Private Limited (Zambon Pharma)
Zambon India Private Limited is the primary company behind Zambon Pharma. The board of Zambon India Private Limited currently have 2 directors; the longest-serving is Sanjiv Khurana, appointed in 2008. 11 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sanjiv Khurana DIN 00524231 | Whole-time director | 01 Apr 2008 | 18 yrs 7 mo | Zambon India Private Limited |
| Laura Meneghetti DIN 10043553 | Director | 06 Feb 2023 | 3 yrs 9 mo | Zambon India Private Limited |
People of Zambon Pharma
1 people are tracked at Zambon Pharma (1 in leadership).
| Name | Role | Group |
|---|---|---|
Roberto Tascione | CEO | Leadership |
Complete people profiles for Zambon Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Zambon Pharma
Figures of Zambon India Private Limited, the primary company behind Zambon Pharma, for FY 2023. Revenue was ₹41.8 Lakh (-2% year on year). Net loss was -₹51.5 Lakh (-123% margin). EBITDA was -₹51.5 Lakh (-123% margin). Revenue has grown at a compounded annual rate of +30% over three years and +12% over five years.
- ₹41.8 LakhRevenue · FY 2023 · -2% YoY
- -₹51.5 LakhNet loss · -123% margin
- -₹51.5 LakhEBITDA · -123% margin
- ₹1.34 CrPaid-up capital
- +30%Revenue CAGR, 3 years
- +12%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Zambon India Private Limited are on its company page.
Detailed financial statements for Zambon Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Zambon Pharma
Zambon Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Breath Therapeutics.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Inhalation therapies are developed for severe respiratory orphan diseases. | breath-therapeutics.com | Munich, Germany | 2016 | Jul 2019 | •••• |
Complete acquisition details for Zambon Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Zambon Pharma
3 dated milestones of Zambon Pharma across 113 years, from founding to its latest funding, stage changes and deals.
- Founded Zambon Pharma is founded.
- Funding First funding round.
- Acquisition Acquires Breath Therapeutics.
Web traffic of Zambon Pharma
The website of Zambon Pharma (zambon.com) receives about 35.1K visits a month and ranks #807,626 among all websites worldwide, #967 in Biotechnology and Pharmaceuticals.
- Monthly visits35.1K
▼ 1.2% vs previous month
- Unique visitors14.7K
per month
- Global rank#807,626
among all websites
- Category rank#967
Health · Biotechnology and Pharmaceuticals
- Bounce rate36%
- Pages per visit2.4
- Average visit2 min 37 sec
- DevicesDesktop 34% · Mobile 66%
Websites whose visitors overlap most with Zambon Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
zambonpharma.com | zambonpharma.com | 100% | #1,752,929 | – | |
zetafarm.it | zetafarm.it | 91% | #5,231,946 | – | |
farmaciarubino.net | farmaciarubino.net | 45% | #844,286 | – | |
| farmani.ru | 45% | #118,260 | View details | ||
medi.ru | medi.ru | 45% | #67,982 | – | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 8 similar websites and full traffic analytics for Zambon Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 8 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zambon Pharma
Complete news archive for Zambon Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zambon Pharma
Zambon Pharma was founded in 1906 and raised its 1st funding round 106 years after it was founded.
Zambon Pharma is headquartered in Bresso, Italy. It is registered at Bresso, Lombardy, Italy.
Roberto Tascione is the CEO of Zambon Pharma, as recorded in our data.
The primary company behind Zambon Pharma, Zambon India Private Limited, reported revenue of ₹41.8 Lakh for FY 2023, down 2% year on year.
Zambon Pharma was founded in 1906 in Bresso, Italy, within the pharmaceutical sector. Active pharmaceutical ingredients and finished drugs are developed and manufactured, alongside research and development focused on patient health improvements. A subsidiary handles digital health technologies to support traditional treatments. A scientific campus is maintained for partnerships in health, science, and innovation. Operations cover the full value chain from research through production and distribution.
Zambon Pharma offers Zambon Pharma, Zach System, and Zcube.
Zambon Pharma has made 1 acquisition, including Breath Therapeutics.
Zambon Pharma has 1 investor. Key investors include European Investment Bank.
Zambon Pharma operates through Zambon India Private Limited.
The legal entities of Zambon Pharma currently have 2 directors, including Sanjiv Khurana, Laura Meneghetti.